Xiaomi’s Hong Kong-listed shares (OTC:XIACF) jumped 8% on Friday following the debut of its latest electric vehicle, the YU7 SUV. The Chinese tech giant, best known for its smartphones, continues its bold push into the electric vehicle (EV) market, drawing investor attention with competitive pricing.
The YU7, unveiled on Thursday, starts at 253,500 yuan (approximately $35,364), positioning it about 4% cheaper than Tesla’s popular Model Y in China. This aggressive pricing strategy signals Xiaomi’s intent to gain ground in the highly competitive EV space, currently dominated by Tesla and other local automakers like BYD.
Shares climbed roughly 5% during early trading before extending gains, reflecting strong market optimism around Xiaomi’s automotive ambitions. The YU7 is part of the company’s broader strategy to diversify beyond smartphones and leverage its brand strength and extensive tech ecosystem to capture a share of the growing EV demand in China.
With China being the world’s largest EV market, Xiaomi’s entry adds fresh momentum to an already dynamic sector. Investors are betting on Xiaomi’s ability to replicate its success in consumer electronics within the EV industry by offering high-tech features at attractive prices.
The surge in Xiaomi shares also highlights broader market enthusiasm for tech-driven EV innovation, especially when backed by well-known brands with strong consumer loyalty. As Xiaomi ramps up production and delivery plans, the YU7 could play a crucial role in challenging established players and accelerating the company’s transformation into a full-fledged EV manufacturer.
Search interest in Xiaomi EVs is expected to rise as the YU7 gains traction, positioning the company as a serious contender in the electric car market.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



